Zhao, Yuxi
Xu, Chanjuan https://orcid.org/0000-0002-5640-1896
Wang, Yue https://orcid.org/0000-0002-3716-2922
Shan, Hong
Wang, Jing https://orcid.org/0009-0006-3929-9267
Liu, Yuxuan https://orcid.org/0009-0007-0799-3227
Luo, Xin
Li, Junrui
Li, Mingyang
Liu, Yini
Wu, Kai
Roth, Bryan L. https://orcid.org/0000-0002-0561-6520
Huang, Xi-Ping https://orcid.org/0000-0002-2585-653X
Xu, H. Eric https://orcid.org/0000-0002-6829-8144
Liu, Jianfeng https://orcid.org/0000-0002-0284-8377
Zhuang, Youwen https://orcid.org/0000-0002-1380-8047
Funding for this research was provided by:
National Natural Science Foundation of China (32401002)
Article History
Received: 10 August 2025
Accepted: 13 May 2026
First Online: 29 May 2026
Competing interests
: H.E.X. is the founder of Cascade Pharmaceutics. All the other authors declare no competing interests.